165 related articles for article (PubMed ID: 17178661)
1. t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience.
Ruiz-Argüelles GJ; Morales-Toquero A; Manzano C; Ruiz-Delgado GJ; Jaramillo P; Gonzalez-Carrillo ML; Reyes-Núñez V
Hematology; 2006 Aug; 11(4):235-8. PubMed ID: 17178661
[TBL] [Abstract][Full Text] [Related]
2. Core binding factor acute myeloid leukemia (CBF-AML) in México: a single institution experience.
Ruiz-Delgado GJ; Macías-Gallardo J; Lutz-Presno J; Garcés-Eisele J; Hernández-Arizpe A; Montes-Montiel M; Ruiz-Argüelles GJ
Rev Invest Clin; 2011; 63(1):25-30. PubMed ID: 21574542
[TBL] [Abstract][Full Text] [Related]
3. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
[TBL] [Abstract][Full Text] [Related]
4. A complex karyotype masked a cryptic variant t(8;21)(q22;q22) in a child with acute myeloid leukemia.
De Figueiredo AF; Liehr T; Bhatt S; Binato R; De Souza MT; De Matos RR; Salles Tde J; Jordy FC; Ribeiro RC; Abdelhay E; Silva ML
Leuk Lymphoma; 2011 Aug; 52(8):1593-6. PubMed ID: 21657952
[No Abstract] [Full Text] [Related]
5. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
6. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH;
Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179
[TBL] [Abstract][Full Text] [Related]
7. Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).
Corral Mdel P; Villa O; Alfaro EM; Alonso CN; Baro C; Felice MS; Rossi J; Solé F; Gallego MS
Pediatr Blood Cancer; 2008 Mar; 50(3):651-4. PubMed ID: 17405156
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
[TBL] [Abstract][Full Text] [Related]
9. Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution's experience.
Lee KW; Choi IS; Roh EY; Kim DY; Yun T; Lee DS; Yoon SS; Park S; Kim BK; Kim NK
Ann Hematol; 2004 Apr; 83(4):218-24. PubMed ID: 14628154
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
[TBL] [Abstract][Full Text] [Related]
11. Complex t(2;21;8)(p12;q22;q22): a variant t(8;21) in a patient with acute myeloid leukemia (AML-M2).
Wang H; Yang W; Shao H; Zhang J; Qi L; Liao A; Li Y; Liu Z
Cancer Genet Cytogenet; 2009 Jan; 188(2):95-8. PubMed ID: 19100512
[TBL] [Abstract][Full Text] [Related]
12. Autologous hematopoietic stem cell transplantation for adults with acute myeloid leukemia in complete remission: the Edouard Herriot Hospital experience.
Michallet AS; Chelghoum Y; Thiebaut A; Le QH; Prebet T; Tavernier E; Antal D; Nicolini F; Troncy J; Elhamri M; Michallet M; Thomas X
Hematology; 2006 Jun; 11(3):157-64. PubMed ID: 17325955
[TBL] [Abstract][Full Text] [Related]
13. Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).
Zhu HH; Jiang H; Jiang Q; Jia JS; Qin YZ; Huang XJ
Leuk Res; 2016 May; 44():40-4. PubMed ID: 26994850
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21).
Shao H; Yang Q; Wu C; Cen J; Chen S; Pan J
Ann Hematol; 2017 Dec; 96(12):2127-2129. PubMed ID: 28840298
[No Abstract] [Full Text] [Related]
15. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.
Kong XT; Ida K; Ichikawa H; Shimizu K; Ohki M; Maseki N; Kaneko Y; Sako M; Kobayashi Y; Tojou A; Miura I; Kakuda H; Funabiki T; Horibe K; Hamaguchi H; Akiyama Y; Bessho F; Yanagisawa M; Hayashi Y
Blood; 1997 Aug; 90(3):1192-9. PubMed ID: 9242552
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and laboratory study of a complex translocation t (6; 21; 8) (p22; q22; q22) in two patients with acute myeloid leukemia].
Gong JY; Liu XP; Li CW; Zhao XC; Dai Y; Qin S; Xiao JG; Huang Q; Xu FY; Wang F; Cui W; Liu SH; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):314-7. PubMed ID: 16875580
[TBL] [Abstract][Full Text] [Related]
17. Good outcome of children with acute myeloid leukemia and t(8;21)(q22;q22), even when associated with granulocytic sarcoma: a report from a single institution in Argentina.
Felice MS; Zubizarreta PA; Alfaro EM; Gallego MS; Cygler AM; Rosso DA; Rossi JG; Sackmann-Muriel F
Cancer; 2000 Apr; 88(8):1939-44. PubMed ID: 10760772
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).
Bacher U; Schnittger S; Kern W; Trenn G; Weisser M; Haferlach T; Schoch C
Cancer Genet Cytogenet; 2006 Jul; 168(2):172-4. PubMed ID: 16843110
[TBL] [Abstract][Full Text] [Related]
19. [Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22)].
Gritsaev SV; Martynkevich IS; Ziuzgin IS; Kariagina EV; Martynenko LS; Petrova EV; Tsybakova NIu; Ivanova MP; Kostroma II; Tiranova SA; Potikhonova NA; Abdulkadyrov KM
Ter Arkh; 2014; 86(7):45-52. PubMed ID: 25314777
[TBL] [Abstract][Full Text] [Related]
20. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
